HUMIRA® Special Investigation (Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis)
HUMIRA® Special Investigation (Long-term Treatment in Patients With Non-infectious Intermediate-, Posterior-, or Pan-uveitis)
This study evaluates the long- term safety and effectiveness of adalimumab in participants with non-infectious intermediate-, posterior-, or pan-uveitis in daily practice in Japan.
Inclusion Criteria:
Exclusion Criteria:
Urayasu-shi, Chiba 279-0021, Japan
Kurume-shi, Fukuoka 830-0011, Japan
Nankoku-shi, Kochi 783-8505, Japan
Matsumoto-shi, Nagano 390-8621, Japan
Suita-shi, Osaka 565-0871, Japan
Iruma-gun, Saitama 350-0451, Japan
Shimotsuga-gun, Tochigi 321-0293, Japan
Bunkyo-ku, Tokyo 113-8431, Japan
Bunkyo-ku, Tokyo 113-8519, Japan
Bunkyo-ku, Tokyo 113-8603, Japan
Bunkyo-ku, Tokyo 113-8655, Japan
Minato-ku, Tokyo 105-8471, Japan
Shinjuku-ku, Tokyo 160-0023, Japan
Shinjuku-ku, Tokyo 162-8655, Japan
Shinjuku-ku, Tokyo 162-8666, Japan
Ube-shi, Yamaguchi 755-8505, Japan
Nishinomiya-shi, 663-8501, Japan